Literature DB >> 17605405

Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol.

Michael Fahie-Wilson1, Christian Bieglmayer, Jürgen Kratzsch, Charly Nusbaumer, Heinz Jürgen Roth, Martina Zaninotto, Mario Plebani, Arnulf Hubbuch, Erich Schneider.   

Abstract

Hyperprolactinaemia due to macroprolactin (MPRL) can lead to misdiagnosis and inappropriate treatment. We studied the new Roche Elecsys Prolactin assay (PRL II) which has been developed to reduce reactivity with MPRL. We investigated the performance of the PRL II assay at six laboratory sites to determine precision and establish reference intervals for total immunoreactive PRL and for monomeric PRL determined by precipitation with polyethylene glycol (PEG). We compared the reactivities with macroprolactin of the PRL II, the PRL I and seven other PRL assays. The PRL II assay reacted less strongly than the PRL I assay and similarly to the ADVIA Centaur assay with macroprolactin. PEG precipitation can be used with the PRL II assay to estimate the concentration of monomeric PRL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17605405

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  1 in total

1.  Prolactin at moderately increased levels confers a neuroprotective effect in non-secreting pituitary macroadenomas.

Authors:  David A Paul; Alejandra Rodrigue; Nicholas Contento; Sam Haber; Ricky Hoang; Redi Rahmani; Adnan Hirad; Ismat Shafiq; Zoë Williams; G Edward Vates
Journal:  PLoS One       Date:  2022-08-03       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.